Business
Which biotech’s shares have hit a 12-month high on good news from the FDA?
Image source: Getty Images
Shareholders in Neuren Pharmaceuticals Ltd (ASX: NEU) are rejoicing after one of the company’s drugs, which shows promise in treating a rare genetic disorder, received fast-track designation from the US Food & Drug Administration (FDA).
Neuren told the ASX in a…
Continue Reading
-
Noosa News16 hours agoForensic teams, dogs descend on scene of alleged murder
-
Noosa News20 hours agoRubber vine weed found in Lockyer Valley for first time in 54 years
-
General20 hours agoAmerican chess grandmaster Daniel Naroditsky dies aged 29
-
Noosa News22 hours agoAlleged thief coaxed out of tree following home invasion